Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 6 November

Sam Kanaan
November 6, 2023

Weekly Wrap 3 November

Grady Wulff
November 3, 2023

Morning Bell 3 November

Sam Kanaan
November 3, 2023

Morning Bell 2 November

Grady Wulff
November 2, 2023

Morning Bell 1 November

Sam Kanaan
November 1, 2023

Morning Bell 31 October

Sam Kanaan
October 31, 2023

Morning Bell 30 October

Grady Wulff
October 30, 2023

Weekly Wrap 27 October

Grady Wulff
October 27, 2023

Morning Bell 27 October

Sam Kanaan
October 27, 2023

Morning Bell 26 October

Grady Wulff
October 26, 2023

Morning Bell 25 October

Sophia Mavridis
October 25, 2023

Morning Bell 24 October

Sam Kanaan
October 24, 2023